Randomized, double-blind, placebo-controlled trial for intravenous dexamethasone as an adjuvant for improving laber analgesia

Intravenous dexamethasone as an adjuvant for improving laber analgesia: Randomized, double-blind, placebo-controlled clinical trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000029165

Enrollment

Unknown

Registered

2020-01-17

Start date

2020-01-20

Completion date

Unknown

Last updated

2020-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intra-partum fever for labor analgesia

Interventions

Experimental group:Convenience treatment plus Dexamethasone

control group:Convenience treatment

Eligibility

Sex/Gender

Female

Age

20 Years to 39 Years

Inclusion criteria

Inclusion criteria: Pregnant women have ASA I ~ II grade before surgery; single pregnancy; aged 20 ~ 39 years old; IBM 20 ~ 28kg / m2.

Exclusion criteria

Exclusion criteria: Women with basal body temperature> 37.5 degree C who have been treated with dexamethasone for 7 days; Pregnancy complications; Pregnant women with abnormal thyroid function; delivery time 8h.

Design outcomes

Primary

Measure	Time frame
body temperature;IL-1 beta;IL-6;TNF-alpha;leucocyte caspase-1 activity;	—

Secondary

Measure	Time frame
VAS score;Bromage score;Apgar score;	—

Countries

China

Contacts

Public ContactSHEN CHAN

Maternal and Child Health Hospital of Hubei Province

sunnyabs1215@163.com+86 18986161977

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026